Regulating Autonomous Vehicles

Abstract

The widespread deployment and testing of autonomous vehicles in real-world environments raises key questions about how such systems should be regulated. Much of the current debate presupposes that the regulatory system we currently use for regular vehicles is also appropriate for semi- and fully-autonomous ones. In opposition, we first argue that there are serious challenges to regulating autonomous vehicles using current approaches, due to the nature of both autonomous capabilities (and their connections to operational domains), and also the systems' tasks and surrounding uncertainties. Instead, we argue that vehicles with autonomous capabilities are similar in key respects to drugs and other medical inter-ventions. Thus, we propose (on a "first principles" basis) a dynamic regulatory system with staged approvals and monitoring, analogous to the system used by the U.S. Food & Drug Administration. We provide details about the operation of such a potential system, and conclude by characterizing its benefits, costs, and plausibility.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 19 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.